Huberman Lab

Podbit · Huberman Lab

Essentials: The Science & Treatment of Obsessive Compulsive Disorder (OCD)

Explore episode Jul 9, 2026

Where this was said

Cortico-Striatal-Thalamic Loop; Imaging Studies, SSRIs

At 11:00 · chapter starts 10:16

This is the episode's richest neuroscience chapter. Huberman describes how researchers have confirmed the cortico-striatal-thalamic loop's role in OCD through deliberately provocative experiments: subjects with contamination OCD are handed towels soaked in a stranger's sweat — sometimes from the back of the experimenter's neck — and placed in brain scanners. The anxiety, obsessions, and compulsive urges that flood in correspond exactly to heightened metabolic activity in this circuit. The evidence becomes even more compelling when drug data is layered on: SSRIs that partially relieve OCD symptoms don't just change behavior, they measurably reduce activity in the same cortico-striatal-thalamic circuit. The convergence of fMRI data, PET scanning, and pharmacological effects from multiple independent research groups creates one of the stronger causal arguments in psychiatric neuroscience. Huberman also teases how understanding this circuit illuminates why each treatment approach — behavioral, pharmacological, or stimulation-based — targets different nodes of the same loop.

Similar podbits

Science
The Placebo Effect Is Not Fake — It Just Belongs to the Story, Not the Drug

#403 ‒ Peptides: separating scientific promise from marketi… · Aug 10, 2026 Science

Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.